CLASS II Drug recall · Reported 14 Oct 2020 · FDA Enforcement Report
Phentermine, 30 mg capsules, Rx only recalled by Calvin Scott & Company
Calvin Scott & Company is recalling Phentermine, 30 mg capsules, Rx only, distributed in California, Idaho, Illinois, Oklahoma, Rhode Island. The recall was initiated on 16 Sep 2020 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0011-2021
- FDA event ID
- 86442
- Recalling firm
- Calvin Scott & Company, Albuquerque, NM
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 16 Sep 2020
- FDA classified
- 2 Oct 2020
- Reported
- 14 Oct 2020
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
Timeline
| 16 Sep 2020 | Recall initiated by company | |
| 2 Oct 2020 | Classified by FDA | +16 days |
| 14 Oct 2020 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Phentermine, 30 mg capsules, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-0597-10
Where it was distributed
Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI
Questions about this recall
Is Phentermine, 30 mg capsules, Rx only recalled?
Yes. Calvin Scott & Company recalled Phentermine, 30 mg capsules, Rx only on 16 Sep 2020. The recall is Class II and its status is Terminated. Recall number D-0011-2021.
Why was it recalled?
cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
Which lots are affected?
Lot #: CS19309, CS20098, Exp 12/21
Where was it sold?
Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Calvin Scott & Company
All 24| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Benzphetamine tablets, 50mg, CIII recalled by Calvin Scott & Company | Calvin Scott & Company | Packaging Defects | GA |
| Drug | CLASS I | Benzonatate capsules, 100mg recalled by Calvin Scott & Company | Calvin Scott & Company | Packaging Defects | GA |
| Drug | CLASS II | Diethylpropion, 75 mg tablets, Rx only recalled | Calvin Scott & Company | Potency & Assay | 5 states |
| Drug | CLASS II | Diethylpropion, 25 mg tablets, Rx only recalled | Calvin Scott & Company | Potency & Assay | 5 states |
| Drug | CLASS II | Topiramate 25mg Tabs White/round tablets recalled | Calvin Scott & Company | Manufacturing (CGMP) Deviations | Nationwide |